Mercer Capital Advisers’s Zimmer Biomet ZBH Stock Holding History

Mercer Capital Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-82	Closed	-$8K	–	227
2018 Q4	$8K	Hold	82	–	–	0.01%	215
2018 Q3	$11K	Hold	82	–	–	0.01%	210
2018 Q2	$9K	Hold	82	–	–	0.01%	234
2018 Q1	$9K	Hold	82	–	–	0.01%	223
2017 Q4	$10K	Hold	82	–	–	0.01%	216
2017 Q3	$9K	Hold	82	–	–	0.01%	225
2017 Q2	$10K	Hold	82	–	–	0.01%	228
2017 Q1	$10K	Hold	82	–	–	0.01%	235
2016 Q4	$8K	Hold	82	–	–	0.01%	247
2016 Q3	$10K	Hold	82	–	–	0.01%	240
2016 Q2	$10K	Hold	82	–	–	0.01%	238
2016 Q1	$9K	Hold	82	–	–	0.01%	242
2015 Q4	$8K	Buy	+82	New	+$8.02K	0.01%	254

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mercer Capital Advisers's ZBH Position: Q1 2019 in Review

Mercer Capital Advisers sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 82 shares — an estimated $8K sold.

Mercer Capital Advisers first reported a position in ZBH in Q4 2015 and held it in 13 quarters. The position peaked at $11K in Q3 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

Mercer Capital Advisers reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
Mercer Capital Advisers sold 82 Zimmer Biomet shares in Q1 2019, an estimated $8K.
Mercer Capital Advisers first reported a position in Zimmer Biomet in Q4 2015 and held it in 13 quarters.
Mercer Capital Advisers's Zimmer Biomet position peaked at $11K in Q3 2018.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Mercer Capital Advisers's 13F filing for Q1 2019, filed 23 Apr 2019.